Ann Thorell
Directeur Financier/CFO chez SERES THERAPEUTICS, INC.
Fortune : 18 680 $ au 30/04/2024
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Eric Shaff | M | 48 | 10 ans | |
| Sanford Zweifach | M | 68 |
Palladio Biosciences, Inc.
 Palladio Biosciences, Inc. BiotechnologyHealth Technology Palladio Biosciences, Inc. develops transformative medicines for orphan diseases. Its pipeline includes Lixivaptan, a selective vasopressin V2 receptor antagonist for the treatment of polycystic kidney disease, a life-threatening genetic disease. The company was founded by Lorenzo Pellegrini in 2015 and is headquartered in Newtown, PA. | 7 ans |
| David Parkinson | M | 73 | 9 ans | |
| Marcus Chapman | M | 53 | 9 ans | |
| Saurabh Saha | M | 47 |
Capella Bioscience Ltd.
 Capella Bioscience Ltd. Pharmaceuticals: MajorHealth Technology Capella Bioscience Ltd. develops medicines based on monoclonal antibodies to the next generation therapeutic targets in oncology and autoimmune disease. The company was founded by Steve Holmes in 2014 and is headquartered in London, the United Kingdom.
ApcinteX Ltd.
 ApcinteX Ltd. BiotechnologyHealth Technology ApcinteX Ltd. develops and markets anticoagulant APC pathway to treat haemophilia. The company is headquartered in London, the United Kingdom. | 3 ans |
| Alex Martin Martin | M | 55 | 9 ans | |
| Stephen Berenson | M | 63 | 5 ans | |
| Mildred C. Joyner | F | 74 |
Living Beyond Breast Cancer
| 16 ans |
| Jean A. Sachs | F | - |
Living Beyond Breast Cancer
| 28 ans |
| Willard Dere | M | 70 | 7 ans | |
| Matthew Henn | M | 49 | 12 ans | |
| Carlo Tanzi | M | - | 9 ans | |
| Samarth Kulkarni | M | 45 | 3 ans | |
| Gary Sollis | M | 69 | 12 ans | |
| Paul Biondi | M | 54 | 4 ans | |
| Carol Stuckley | F | 68 | 3 ans | |
| Jennifer Russo Wortman | F | - | 9 ans | |
| Lauren Merendino | F | 49 | 1 ans | |
| Mathias Hukkelhoven | M | 70 | 2 ans | |
| Antoine Yver | M | 66 | 3 ans | |
| Franklin Berger | M | 74 | 9 ans | |
| Dennis Ausiello | M | 78 | 9 ans | |
| Claire Fraser-Liggett | M | 68 | 1 ans | |
| Richard Glickman | M | 65 | 14 ans | |
| Thomas DesRosier | M | 69 | 8 ans | |
| Gregory Mark Weinhoff | M | 53 | 3 ans | |
| Brett Zbar | M | 51 | 3 ans | |
| Scott Requadt | M | 56 | 8 ans | |
| Richard Kender | M | 68 | 10 ans | |
| Kurt Graves | M | 56 | 9 ans | |
| Philip Kantoff | M | 69 | 2 ans | |
| Kristen K. Sheppard | F | - | 2 ans | |
| Mary Lynne Hedley | M | 61 | 3 ans | |
| Marisa Gefen | F | - |
Living Beyond Breast Cancer
| - |
| Rebecca Dougherty | F | - |
Living Beyond Breast Cancer
| - |
| Theresa Frangiosa | F | - |
Living Beyond Breast Cancer
| - |
| David Chao | M | 56 | 3 ans | |
| Iqbal Hussain | M | 43 | 3 ans | |
| Philip M. Browne | M | 64 |
Living Beyond Breast Cancer
| - |
| Iqbal Hussain | M | 43 |
ApcinteX Ltd.
ApcinteX Ltd. BiotechnologyHealth Technology ApcinteX Ltd. develops and markets anticoagulant APC pathway to treat haemophilia. The company is headquartered in London, the United Kingdom. | - |
| David Ege | M | 50 | 4 ans | |
| Nancy Lyskawa | F | 61 |
Living Beyond Breast Cancer
| - |
| Teresa Young | M | 57 | 4 ans | |
| Kelly M. Brady | F | - | 6 ans | |
| Lisa von Moltke | M | 65 | 4 ans | |
| Alessandra Cesano | M | 63 | 5 ans | |
| Barbara McGovern | M | - | 9 ans | |
| David Wood | M | 66 | 11 ans | |
| Arjun Goyal | M | - | 3 ans | |
| Sanford Lipstein | M | - |
Living Beyond Breast Cancer
| - |
| Peter Virsik | M | - | 8 ans | |
| John K. McDonald | M | 87 |
Living Beyond Breast Cancer
| - |
| Harris Rotman | M | - | 2 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Simba Gill | M | 60 | 8 ans | |
| Michael Richard Dwyer Ashton | M | 77 | 3 ans | |
| Raymond J. Andersen | M | 76 | 10 ans | |
| David Epstein | M | 62 | 6 ans | |
| Jim Walsh | M | 65 | 6 ans | |
| Charles Spicer | M | 59 | 6 ans | |
| Lord Darzi | M | 63 | 5 ans | |
| Gregory Todd Bosch | M | 61 | 8 ans | |
| Darren Douglas Weiss | M | 52 | 7 ans | |
| Ivan Philip Gergel | M | 64 | 2 ans | |
| Andrea Holtzman Drucker | F | 66 | 5 ans | |
| Juan Andres | M | 59 | 4 ans | |
| Theo Melas-Kyriazi | M | 64 | 6 ans | |
| Mark Sampson | M | - | 18 ans | |
| Joseph William Birkett | M | 76 | 20 ans | |
| W. Hertz | M | 54 | - | |
| Joseph Payne | M | 52 | 5 ans | |
| Ofir Levi | M | 50 | 4 ans | |
| John Hohneker | M | 64 | 2 ans | |
| Aaron Kantoff | M | 29 | 1 ans | |
| Tonya Williams | F | 50 | 1 ans | |
| Meenu Chhabra Karson | F | 51 | 1 ans | |
| Peter Larkin | M | 70 | 3 ans | |
| Alan Suggett | M | 80 | 2 ans | |
| Leanne Kelly | F | 47 | - | |
| Keith Goldan | M | 52 | 4 ans | |
| Otello Stampacchia | M | 55 | 1 ans | |
| Alexander Reynolds | M | - | - | |
| Ari Brettman | M | 42 | 2 ans | |
| Mihalis Sapountzoglou | M | 63 | 9 ans | |
| Jonathan Zung | M | 59 | 2 ans | |
| Camilla Simpson | F | 52 | - | |
| Timothy J Whitaker | M | 66 | 5 ans | |
| Raj Bhikhu Parekh | M | 63 |
Capella Bioscience Ltd.
Capella Bioscience Ltd. Pharmaceuticals: MajorHealth Technology Capella Bioscience Ltd. develops medicines based on monoclonal antibodies to the next generation therapeutic targets in oncology and autoimmune disease. The company was founded by Steve Holmes in 2014 and is headquartered in London, the United Kingdom. | 7 ans |
| Robert L. Rosiello | M | 66 | - | |
| Jeffrey Moore | M | 63 | - | |
| Jose-Carlos Gutiérrez-Ramos | M | 61 | 1 ans | |
| Bishop Julius Allen | M | 76 | 5 ans | |
| David Szekeres | M | 50 | - | |
| Roelof Rongen | M | 59 | - | |
| Robert M. Califf | M | 72 | 1 ans | |
| Matthew Hammond | M | 49 | 7 ans | |
| Thomas S. Templeman | M | 64 | 2 ans | |
| Julie McHugh | F | 59 | 2 ans | |
| Danny Robert Hegglin | M | 62 | 4 ans | |
| Neil Thomas Blewitt | M | 64 | - | |
| Christopher Wightman | M | 66 | 14 ans |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 50 | 50,00% |
| Royaume-Uni | 40 | 40,00% |
| Canada | 15 | 15,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Ann Thorell
- Réseau Personnel
